New Capability Responds to Growing Demand by Physicians Who Rely Heavily on Their Mobile Devices

NANUET, N.Y. — iMedicor, a Vemics Company (OTCBB: VMCI), today announced that it has entered into an agreement with myLEADERBOARD, Inc. to complete the development of a mobile application of its online communications platform, responding to the growing demand by physicians who rely heavily on their handheld devices to deliver a higher quality of care to their patients. The application will be available at no cost through the iMedicor portal. 

“iMedicor is working with myLEADERBOARD to deliver this new functionality within 60-90 days,” said iMedicor CEO Fred Zolla. “According to Manhattan Research, over 64% of all physicians use mobile devices such as an iPhone and / or BlackBerry in their daily practices, up 20% between 2008 and 2009. We look forward to integrating these and other proven mobile applications to enhance iMedicor’s ability to support physician workflow.”

iMedicor is the market’s leading HIPAA-compliant solution for interoperable medical information transfer that is offered at no cost to physicians, healthcare providers, and patients. Within iMedicor, health information can be exchanged across disparate EMR’s to communicate, collaborate and exchange medical records for referrals and patient communications. iMedicor provides access to CME (Continuing Medical Education) product-specific educational resources, and to electronic prescription ordering and refills.

“We’re very pleased to be able to leverage our proprietary mobile platform and technology to support iMedicor’s plan to expand its unique services by offering mobile applications,” said myLEADERBOARD CEO John Geary.

The iMedicor portal operates via secure messaging specifically designed to complement clinical workflow, and it delivers on the Obama Administration’s call for an interoperable health information infrastructure that allows healthcare providers to become interconnected. “We believe adding mobile functionality to iMedicor’s platform brings even greater flexibility to healthcare providers, and offers one more distinguishing feature to our technology as the Administration moves toward EMR interoperability,” said Tom Dorsett, President of iMedicor.

About iMedicor, a Vemics Company:

Vemics’ iMedicor is the only HIPAA-compliant solution for interoperable health information transfer that is offered at no cost to healthcare providers. The iMedicor portal enables disparate EMR (electronic medical record) systems to communicate, collaborate and exchange records in real time; pharmaceutical companies to deliver customized educational marketing programs to more than 730,000 healthcare providers nationwide in a highly targeted, cost-effective and non-intrusive manner; and allows doctors, administrators and other qualified healthcare workers to send and receive medical records, files and images. More information on iMedicor is available at www.imedicor.com.

About myLeaderBoard:

myLEADERBOARD, Inc. develops mobile software solutions for businesses and brands which create efficient, adaptable and highly reliable mobile platforms to deliver user-directed content, communication and commerce. The myLEADERBOARD proprietary mobile platform supports highly complex, real-time secure data transfer, database queries and advanced user analytics, coupled with a sophisticated ad server platform to deliver customized, hyper-targeted mobile marketing. Mobile operating systems supported include the iPhone, BlackBerry, Android, Windows Mobile and Palm, as well as mobile web for browser only enabled phones. More information on myLEADERBOARD is available at www.myleaderboard.com.

The statements contained herein, other than historical information, are or may be deemed to be forward-looking statements and involve factors, risks, and uncertainties that may cause actual results in future periods to differ materially from such statements. These factors, risks, and uncertainties include market acceptance of Vemics’ products and services; the nonexclusive and terminable-at-will nature of certain of the company’s partnerships and agreements; rapid technological change affecting demand for our products and services; competition from companies providing similar products and services, availability of sufficient financial resources to enable us to expand our operations, as well as other risks detailed from time to time in our filings with the Securities and Exchange Commission.